Literature DB >> 15041925

Fibromyalgia: state of the art.

P Fietta1.   

Abstract

Fibromyalgia (FM) is a common and complex condition, defined as long lasting, widespread musculoskeletal pain, in the presence of tender points (TPs) at specific anatomical sites. Dysautonomic and functional symptoms, such as orthostatic hypotension, tachycardia, effort intolerance, marked fatigue, sleep disorders, cognitive disturbances, psychological distress, paresthesias, headache, genitourinary manifestations, irritable bowel syndrome and bladder dyskinesia, frequently occur. The etiopathogenesis of FM is presently unknown, but nociceptor, autonomic and neuro-endocrine system dysfunctions have been found in patients. Since specific serological or instrumental markers of the syndrome are not yet identifiable, TP search is the only useful diagnostic hallmark. The development of an effective therapy of FM has hitherto been hampered by the incomplete knowledge of its pathogenic mechanisms. In this paper, the most recent information on FM is reviewed.

Entities:  

Mesh:

Year:  2004        PMID: 15041925

Source DB:  PubMed          Journal:  Minerva Med        ISSN: 0026-4806            Impact factor:   4.806


  4 in total

1.  Urodynamic study and quality of life in patients with fibromyalgia and lower urinary tract symptoms.

Authors:  Maíta Poli de Araújo; Alex Carvalho Faria; Claudia Cristina Takano; Emerson de Oliveira; Marair Gracio Ferreira Sartori; Daniel Feldman Pollak; Manoel Joâo Batista Castello Girão
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-03-04

2.  Risk for Irritable Bowel Syndrome in Fibromyalgia Patients: A National Database Study.

Authors:  Tse-Yen Yang; Chih-Sheng Chen; Cheng-Li Lin; Wei-Ming Lin; Chua-Nan Kuo; Chia-Hung Kao
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

3.  Prolonged gabapentin analgesia in an experimental mouse model of fibromyalgia.

Authors:  Michiko Nishiyori; Hiroshi Ueda
Journal:  Mol Pain       Date:  2008-11-06       Impact factor: 3.395

4.  Risk for irritable bowel syndrome in fibromyalgia patients: a national database study.

Authors:  Tse-Yen Yang; Chih-Sheng Chen; Cheng-Li Lin; Wei-Ming Lin; Chua-Nan Kuo; Chia-Hung Kao
Journal:  Medicine (Baltimore)       Date:  2015-03       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.